Assignee
NEURORIVE INC
KR·1 granted patent·3 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
4 records- 0148US2023405004A1Combination therapy of donepezil and tadalafil for the treatment of alzheimer's disease or cognitive impairmentNEURORIVE INC·Filed 2021·Application pending·0 cites
- 0248US2023398106A1Combination therapy of donepezil and sildenafil for the treatment of alzheimer's disease or cognitive impairmentNEURORIVE INC·Filed 2021·Application pending·0 cites
- 0341US12303530B2Combination therapy of cycloserine and lithium for the treatment of depressionNEURORIVE INC·Filed 2020·Granted May 20, 2025·0 cites·6 claims
- 0439US2023165866A1Cycloserine and pentoxifylline combination therapy for treatment of depressionNEURORIVE INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →